Snowden Capital Advisors LLC Fulgent Genetics, Inc. Transaction History

Snowden Capital Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$28.52 - $40.7 $7,643 - $10,907	-268 Reduced 1.33%	19,821 $733,000
Q1 2023 May 15, 2023	SELL	$29.39 - $36.27 $11,109 - $13,710	-378 Reduced 1.85%	20,089 $627,000
Q4 2022 Feb 13, 2023	SELL	$29.23 - $40.28 $51,006 - $70,288	-1,745 Reduced 7.86%	20,467 $609,000
Q3 2022 Nov 09, 2022	BUY	$37.92 - $63.74 $19,680 - $33,081	519 Added 2.39%	22,212 $846,000
Q2 2022 Aug 12, 2022	BUY	$47.98 - $62.75 $8,540 - $11,169	178 Added 0.83%	21,693 $1.18 Million
Q1 2022 May 16, 2022	BUY	$49.85 - $96.11 $940,420 - $1.81 Million	18,865 Added 711.89%	21,515 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $204,845 - $278,250	2,650 New	2,650 $266,000
Q3 2021 Feb 05, 2024	BUY	$74.87 - $110.87 $297,982 - $441,262	3,980 New	3,980 $358 Million
Q2 2021 Jan 08, 2024	SELL	$66.8 - $100.45 $3,340 - $5,022	-50 Reduced 1.28%	3,870 $357 Million
Q1 2021 Jan 08, 2024	SELL	$59.3 - $183.85 $15,418 - $47,801	-260 Reduced 6.22%	3,920 $379 Million
Q4 2020 Jan 08, 2024	BUY	$31.01 - $52.1 $129,621 - $217,778	4,180 New	4,180 $218 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.